A simple score for estimating the long-term risk of fracture in patients with multiple sclerosis

Objective: To derive a simple score for estimating the long-term risk of osteoporotic and hip fracture in individual patients with MS. Methods: Using the UK General Practice Research Database linked to the National Hospital Registry (1997–2008), we identified patients with incident MS (n = 5,494). They were matched 1:6 by year of birth, sex, and practice with patients without MS (control subjects). Cox proportional hazards models were used to calculate the long-term risk of osteoporotic and hip fracture. We fitted the regression model with general and specific risk factors, and the final Cox model was converted into integer risk scores. Results: In comparison with the FRAX calculator, our risk score contains several new risk factors that have been linked with fracture, which include MS, use of antidepressants, use of anticonvulsants, history of falling, and history of fatigue. We estimated the 5- and 10-year risks of osteoporotic and hip fracture in relation to the risk score. The C-statistic was moderate (0.67) for the prediction of osteoporotic fracture and excellent (0.89) for the prediction of hip fracture. Conclusion: This is the first clinical risk score for fracture risk estimation involving MS as a risk factor.

[1]  Yvonne Vergouwe,et al.  Prognosis and prognostic research: validating a prognostic model , 2009, BMJ : British Medical Journal.

[2]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.

[3]  J. Herbert,et al.  Fracture history and bone loss in patients with MS , 1998, Neurology.

[4]  C. Cooper,et al.  Interpretation and use of FRAX in clinical practice , 2011, Osteoporosis International.

[5]  J. Hentz,et al.  Depression, fracture risk, and bone loss: a meta-analysis of cohort studies , 2010, Osteoporosis International.

[6]  G. Gronseth,et al.  Invited Article: Practice parameters and technology assessments , 2008, Neurology.

[7]  J. Herbert,et al.  High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis , 1994, Neurology.

[8]  J. David,et al.  The multiple faces of autoimmune-mediated bone loss , 2010, Nature Reviews Endocrinology.

[9]  K. Nakken,et al.  Bone loss associated with use of antiepileptic drugs , 2010, Expert opinion on drug safety.

[10]  M. Ramanathan,et al.  Risk of bone loss in men with multiple sclerosis , 2004, Multiple sclerosis.

[11]  Chi C Cho,et al.  Risk factors for falling among people aged 45 to 90 years with multiple sclerosis. , 2006, Archives of physical medicine and rehabilitation.

[12]  A. Parfitt,et al.  Osteocyte Apoptosis Is Induced by Weightlessness in Mice and Precedes Osteoclast Recruitment and Bone Loss , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  Chi C Cho,et al.  Injurious falls among middle aged and older adults with multiple sclerosis. , 2008, Archives of physical medicine and rehabilitation.

[14]  C. Chenu,et al.  Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells. , 2006, Bone.

[15]  S. Ozgoçmen,et al.  Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity , 2005, Journal of Bone and Mineral Metabolism.

[16]  Jacques P. Brown,et al.  The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women , 2007, Osteoporosis International.

[17]  P. Vestergaard,et al.  Incidence of fractures in patients with multiple sclerosis: the Danish National Health Registers , 2012, Multiple sclerosis.

[18]  A. Bertolotto,et al.  Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis. , 2004, The Journal of clinical endocrinology and metabolism.

[19]  G. Gronseth,et al.  Invited Article: Lost in a jungle of evidence , 2008, Neurology.

[20]  W A Ray,et al.  Antidepressants and the risk of falls among nursing home residents. , 1998, The New England journal of medicine.

[21]  Cecilia Lundholm,et al.  Predicting accidental falls in people with multiple sclerosis — a longitudinal study , 2009, Clinical rehabilitation.

[22]  O. Johnell,et al.  FRAX™ and the assessment of fracture probability in men and women from the UK , 2008, Osteoporosis International.

[23]  N. D. Nguyen,et al.  Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks , 2008, Osteoporosis International.

[24]  C. Cooper,et al.  The Risk of Fracture in Patients With Multiple Sclerosis: The UK General Practice Research Database , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  Robert A Gross,et al.  Levels of evidence , 2008, Neurology.

[26]  L Abenhaim,et al.  The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results , 2000, Pharmacoepidemiology and drug safety.

[27]  J. Herbert,et al.  Reduced Bone Mass and Fat-Free Mass in Women with Multiple Sclerosis: Effects of Ambulatory Status and Glucocorticoid Use , 1997, Calcified Tissue International.

[28]  A. Siva,et al.  Bone status in multiple sclerosis: beyond corticosteroids , 2003, Multiple sclerosis.

[29]  T. Walley,et al.  The UK General Practice Research Database , 1997, The Lancet.